173 related articles for article (PubMed ID: 25651708)
1. The effect of cell concentrations from different cell populations on the viability of umbilical blood stem cells.
Hauck-Dlimi B; Dlimi A; Zimmermann R; Eckstein R; Zingsem J
Clin Lab; 2014; 60(10):1635-40. PubMed ID: 25651708
[TBL] [Abstract][Full Text] [Related]
2. Quality comparison of umbilical cord blood cryopreserved with conventional versus automated systems.
Kim KM; Huh JY; Kim JJ; Kang MS
Cryobiology; 2017 Oct; 78():65-69. PubMed ID: 28716596
[TBL] [Abstract][Full Text] [Related]
3. Assessment of cell viability, early apoptosis, and hematopoietic potential in umbilical cord blood units after storage.
Kim KM; Huh JY; Hong SS; Kang MS
Transfusion; 2015 Aug; 55(8):2017-22. PubMed ID: 25858170
[TBL] [Abstract][Full Text] [Related]
4. The influence of temperature treatment before cryopreservation on the viability and potency of cryopreserved and thawed CD34
Schwandt S; Liedtke S; Kogler G
Cytotherapy; 2017 Aug; 19(8):962-977. PubMed ID: 28645734
[TBL] [Abstract][Full Text] [Related]
5. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
[TBL] [Abstract][Full Text] [Related]
6. The ROCK inhibitor Y-27632 negatively affects the expansion/survival of both fresh and cryopreserved cord blood-derived CD34+ hematopoietic progenitor cells: Y-27632 negatively affects the expansion/survival of CD34+HSPCs.
Bueno C; Montes R; Menendez P
Stem Cell Rev Rep; 2010 Jun; 6(2):215-23. PubMed ID: 20180051
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo expansion of megakaryocyte progenitors from cryopreserved umbilical cord blood. A potential source of megakaryocytes for transplantation.
Pick M; Eldor A; Grisaru D; Zander AR; Shenhav M; Deutsch VR
Exp Hematol; 2002 Sep; 30(9):1079-87. PubMed ID: 12225800
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two methodologies for the enrichment of mononuclear cells from thawed cord blood products: The automated Sepax system versus the manual Ficoll method.
Kaur I; Zulovich JM; Gonzalez M; McGee KM; Ponweera N; Thandi D; Alvarez EF; Annandale K; Flagge F; Rezvani K; Shpall E
Cytotherapy; 2017 Mar; 19(3):433-439. PubMed ID: 28034522
[TBL] [Abstract][Full Text] [Related]
9. Albumin-based solution is the ideal post-thawing suspension medium for cord blood hematopoietic stem cells: A stability and proliferative evaluation.
Lachica CA; Miele MJ; Herrera SM; Elanbari M; Deola S; Saleh A; Ejaz A; Aftab S; Olagunju D; Laoun R; Cugno C
Transfusion; 2023 May; 63(5):1050-1059. PubMed ID: 37036040
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing cord blood viability assessment before cryopreservation.
Solomon M; Wofford J; Johnson C; Regan D; Creer MH
Transfusion; 2010 Apr; 50(4):820-30. PubMed ID: 19919556
[TBL] [Abstract][Full Text] [Related]
11. Human Leukocyte Antigen and Red Blood Cells Impact Umbilical Cord Blood CD34
Vanegas D; Galindo CC; Páez-Gutiérrez IA; González-Acero LX; Medina-Valderrama PT; Lozano JC; Camacho-Rodríguez B; Perdomo-Arciniegas AM
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31575081
[TBL] [Abstract][Full Text] [Related]
12. Quality of umbilical cord blood CD34+ cells in a double-compartment freezing bag cryopreserved without a rate-controlled programmed freezer.
Minegishi M; Itoh T; Fukawa N; Kitaura T; Miura J; Takahashi H; Suzuki A; Kudo Y; Narita A; Sato Y; Suzuki M; Watanabe T; Wada Y; Takeyama Y; Tsuchiya S
Int J Hematol; 2007 Jan; 85(1):78-84. PubMed ID: 17261506
[TBL] [Abstract][Full Text] [Related]
13. Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells.
Kekarainen T; Mannelin S; Laine J; Jaatinen T
BMC Cell Biol; 2006 Aug; 7():30. PubMed ID: 16882340
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the reactivity of apoptosis markers before and after cryopreservation in cord blood CD34(+) cells.
Greco NJ; Seetharaman S; Kurtz J; Lee WR; Moroff G
Stem Cells Dev; 2006 Feb; 15(1):124-35. PubMed ID: 16522170
[TBL] [Abstract][Full Text] [Related]
15. Platelet characteristic antigens of CD34+ cells in cryopreserved cord blood: a study of platelet-derived microparticles in transplant processing.
Liu B; Chen JS; Cao M; Gu SL; Liao C; Li DZ; Zhong HZ
Vox Sang; 2004 Aug; 87(2):96-104. PubMed ID: 15355500
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Ceprate LC34 affinity system for the enrichment of CD34+ hematopoietic stem cells from cord blood.
Kögler G; Somville T; Werner P
Blood Cells; 1994; 20(2-3):371-5. PubMed ID: 7538341
[TBL] [Abstract][Full Text] [Related]
17. Successful short-term cryopreservation of volume-reduced cord blood units in a cryogenic mechanical freezer: effects on cell recovery, viability, and clonogenic potential.
Anagnostakis I; Papassavas AC; Michalopoulos E; Chatzistamatiou T; Andriopoulou S; Tsakris A; Stavropoulos-Giokas C
Transfusion; 2014 Jan; 54(1):211-23. PubMed ID: 23692393
[TBL] [Abstract][Full Text] [Related]
18. Cryopreservation of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cells.
Duchez P; Chevaleyre J; Brunet de la Grange P; Vlaski M; Boiron JM; Wouters G; Ivanovic Z
Transfusion; 2013 Sep; 53(9):2012-9. PubMed ID: 23227804
[TBL] [Abstract][Full Text] [Related]
19. Differences between peripheral blood and cord blood in the kinetics of lineage-restricted hematopoietic cells: implications for delayed platelet recovery following cord blood transplantation.
Yasui K; Matsumoto K; Hirayama F; Tani Y; Nakano T
Stem Cells; 2003; 21(2):143-51. PubMed ID: 12634410
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cord blood CD34+ cells purified after cryopreservation.
Nicol A; Nieda M; Donaldson C; Denning-Kendall P; Bradley B; Hows J
Exp Hematol; 1995 Dec; 23(14):1589-94. PubMed ID: 8542951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
